Dermatology sits at the intersection of medical and cosmetic care, and practices with a strong cosmetic, cash-pay mix alongside medical dermatology tend to draw the broadest buyer interest — since cosmetic revenue isn't subject to the reimbursement pressure that affects insurance-billed medical dermatology, within Healthcare's 6–9x EBITDA range.
Buyers evaluating a dermatology practice typically look at:
Dermatology Practices businesses are valued within the broader Healthcare Businesses range. Your specific financials, provider/staff dependency, and payer mix determine where you land.
Dermatology-focused PE platforms and MSOs are the most active acquirers, along with other dermatology groups expanding their footprint. Nationally, private equity has named healthcare among the sectors it's most actively pursuing, with PE participation running in the 44-58% range across the industries it favors most, and strategic buyers often paying 10% or more above a PE offer when an acquisition fills a specific gap in their footprint. Overall healthcare deal volume cooled somewhat in the most recent reporting period, but deals for practice-level businesses like this one actually rose by roughly half over the same stretch — a sign buyers are still actively acquiring at this level even as larger platform deals slow.
Often, yes — cosmetic revenue tends to carry higher margins and isn't subject to payer reimbursement cuts, which buyers generally view favorably, though a strong medical dermatology base still matters.
Board certification and provider credentials are a diligence factor, but overall practice financials and patient retention typically weigh more heavily in the valuation itself.
That's common and not automatically a negative — buyers will look at how those providers are supervised and retained, since a well-run PA/NP model can still deliver strong, scalable margins.
Dermatology-focused PE platforms and MSOs have remained active acquirers even as broader M&A activity cooled elsewhere in healthcare, particularly for practices with a strong cosmetic revenue mix. Your own financials and provider mix still shape the actual timing decision.
Not quite the right fit? Here are the other business types Forefront works with in this category.